Covid19
Showing NaN - NaN of 20
Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)
Completed
- Covid19
- Remdesivir
- +4 more
-
Tucson, Arizona
- +39 more
Dec 16, 2022
Asymptomatic SARS-CoV-2 Detection in Children
Completed
- Covid19
- SARS-CoV-2
-
Birmingham, Alabama
- +4 more
Nov 1, 2022
Blood Purification With Seraph 100 Microbind Affinity Blood
Active, not recruiting
- Covid19
- Observational
-
Los Angeles, California
- +13 more
Oct 31, 2022
COVID-19 Citizen Science Expansion Project
Enrolling by invitation
- Covid19
-
Sacramento, California
- +8 more
Sep 30, 2022
Covid19, ME/CFS, SARS COV2 Trial in United States
Active, not recruiting
- Covid19
- +5 more
-
Los Angeles, California
- +7 more
Sep 1, 2022
Covid19 Trial in South Africa, United States (Part A: Upamostat 200 mg, Part A: Upamostat 400 mg, Part A and B: Placebo)
Suspended
- Covid19
- Part A: Upamostat 200 mg
- +3 more
-
Cutler Bay, Florida
- +16 more
Aug 2, 2022
2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in United States (Famotidine,
Terminated
- 2019 Novel Coronavirus Disease
- +11 more
- Famotidine
- +2 more
-
Newport Beach, California
- +14 more
Jul 20, 2022
Covid19, SARS-CoV Infection, Corona Virus Infection Trial in Singapore, United States (ARCT-021 single dose priming, ARCT-021
Terminated
- Covid19
- +2 more
- ARCT-021 single dose priming
- +5 more
-
Chandler, Arizona
- +14 more
Jul 7, 2022
Covid19 Trial in United States (Apixaban 2.5 MG, Placebo)
Active, not recruiting
- Covid19
- Apixaban 2.5 MG
- Placebo
-
Phoenix, Arizona
- +120 more
Jul 1, 2022
Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)
Recruiting
- Covid19
- theraputic heparin
- +4 more
-
Birmingham, Alabama
- +101 more
Jun 28, 2022
Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol
Active, not recruiting
- Acute Kidney Failure
- +10 more
-
New Haven, Connecticut
- +3 more
May 18, 2022
COVID, SARS-CoV2 Infection, Covid19 Trial in Worldwide (Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG), Placebo)
Recruiting
- COVID
- +2 more
- Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)
- Placebo
-
Washington, District of Columbia
- +37 more
Mar 25, 2022
Corona Virus Infection, Covid19, COVID-19 Trial in Worldwide (Awake Proning)
Completed
- Corona Virus Infection
- +2 more
- Awake Proning
-
Dallas, Texas
- +16 more
Oct 14, 2021